This year is the centenary of the death of Elie Metchnikoff, the father of innate immunity. His work on phagocytosis has continued to flourish, particularly over the past half century.
The life and work of Elie Metchnikoff (1845 Metchnikoff ( -1916 ) is a study of contrasts, pessimism followed by optimism, from Imperial Russia to the Pasteur Institute, comparative embryology to experimental pathology. And yet his discovery of the significance of phagocytosis reveals an underlying continuity, which serves as a thread from intracellular digestion, through a system of wandering phagocytes, to integrity of the organism and resistance to infection. After initial resistance and eclipse by more chemically defined innate and adaptive immunity, recent decades have seen a dramatic resurgence of research: discovery of dendritic cells (DCs), antigen processing and presentation, clearance of apoptotic cells by macrophages without inflammation, autophagy as analogous to heterophagy, symbiosis of the host and intestinal flora, and aging and senility. Nobel awards to Metchnikoff and Ehrlich in 1908 and to Steinman, Beutler, and Hoffmann in 2011 bookend these two phases of discovery, linked by phagocytosis.
His life is well described in an (auto) biography (Metchnikoff, 1921) , memoirs recollected in later life Metchnikoff (1959) , and a recent biography by Vikhanski (2016) . His intellectual background and single-minded hypothesis of the role of phagocytosis in immunobiology are detailed in monographs by himself (Metchnikoff, 1968 (Metchnikoff, , 1905 and placed in context by Alfred Tauber and Leon Chernyak (Tauber and Chernyak, 1991) . We are left with a portrait of a volatile, polemical, yet benign genius, who is a somewhat unreliable witness to his own Eureka discovery at Messina (Metchnikoff, 2016) and, in his wholehearted tribute to friend and colleague Alexander Kovalevsky (Metchnikoff, 1959) , to his own previous critical response. Metchnikoff was a zoologically trained biologist who used microscopy and intravital observations on invertebrate marine organisms to trace early germ layer formation during development (Tauber and Chernyak, 1991; Gilbert, 1994) . He had a somewhat delayed acceptance of Darwin's theory, then placed his own phagocytosis hypothesis in an evolutionary context. His observations on phagocytosis followed a life-long interest in intracellular digestion, often using transparent, intact organisms. These studies brought conflict with Haeckel, a Darwinian protagonist of ontogeny in relation to phylogeny.
Metchnikoff ( Figure 1 ) was not the first to observe phagocytosis (Tauber and Chernyak, 1991; Stossel, 1999) , but he grasped its significance in organismal homeostasis by mesodermal amoebocytes, as well as in host defense. In contrast with contemporary pathologists, he saw particle engulfment as an active process of destruction within vacuoles and not merely as a niche for microbial growth and dissemination throughout the body. This was supported by Virchow, the father of cellular pathology, and Claus, who suggested the felicitous name of Phagocytosis (Greek: phagein, eating, kytos, cell), rather than of ''devouring cells.'' Again, Metchnikoff was not the first to describe vascular changes and leukocyte extravasation during inflammation: he observed rapid adhesion to the vascular wall, diapedesis, and aggregation of ''microphages'' (neutrophils or polymorphonuclear leukocytes) during acute inflammation, accompanied by phagocytosis by blood-derived and wandering tissue ''macrophages'' as a physiological host response, rather than purely pathological tissue destruction following injury or infection. To defend the universality of his hypothesis, he investigated a wide variety of microbial challenges including anthrax and typhus in frogs and mammals, revealing differences among species and microbes in innate resistance to infection. He was intrigued by the hostpathogen struggle ending in recovery or death of either participant. This coincided with the identification of Mycobacterium tuberculosis (Koch) and cholera vibrio (Pfeiffer), among others, but evoked little interest among microbiologists, unlike Metchnikoff, in the host's role in pathogenesis and resistance.
Metchnikoff's hypothesis met with fierce criticisms even before the demonstration by von Behring and Kitasato of humoral (antibody-dependent) protective immunity to diphtheria toxin and the discovery of ''alexines'' (complement) by Ehrlich. He staunchly held his ground, not allowing alternative humoral or cellular contributions to specific immunity, in addition to phagocytosis. In contrast with Ehrlich, who conceived of specific receptor-ligand interactions between immune cells, antigenic chemicals, and antiserum (the side-chain hypothesis), Metchnikoff did not investigate immune recognition of the individual self, although its fundamental importance in biological identity had been foreseen. Curiously, when Metchnikoff and Ehrlich were being considered for a Nobel Prize, Ehrlich's nomination was blocked by Arrhenius, the influential Swedish Nobel chemist laureate, on the grounds that Ehrlich was not a competent chemist! Metchnikoff's move to the Pasteur Institute in 1888 and the support of Pasteur resulted in a productive period of scholarship, promoting and defending his earlier experiments on phagocytosis and inflammation, extending his thinking to host interactions with intestinal microbes, and developing a philosophy of harmony in the body and its disruption, termed dysbiosis. He foresaw that human longevity could be influenced by microbes and their toxins. Senescence followed phagocytic clearance and digestion of effete or damaged cells, loss of muscle, nerve degeneration, and other features of advancing age. He coined the term gerontology and is widely acknowledged as a pioneer in the study of aging, not least by introducing lactobacilli as probiotics to promote intestinal health. He established a successful laboratory at the Pasteur, and collaborated with Roux in establishing a primate model to study syphilis but lost out to Ehrlich's discovery of a therapeutic agent, Salvarsan. Distinguished members of his research group included Besredka, Haffkine, and Bordet.
His fame was already established before his Nobel award, after which he made a triumphant visit to Russia, including a memorable meeting with Tolstoy. Neither savant yielded to the other, Tolstoy as a spiritual, literary giant, Metchnikoff as an ardent vivisectionist whose faith had always been science. Among many visitors at the Pasteur were Lister, promoting antisepsis during surgery, and Wright, proponent of opsonic phagocytosis, spoofed by Shaw in The Doctor's Dilemma.
Metchnikoff's Legacy, a Second Phase Although for 50 years after his death, phagocytosis-related research remained associated with Metchnikoff, the second half century to the present has seen a renaissance in phagocyte biology in health and disease, culminating in the Nobel award of 2011. This body of new knowledge is a tribute to Metchnikoff's anticipation of much contemporary investigation. We can date onset of this second phase in Metchnikoff's legacy to the establishment of the Hirsch-Cohn laboratory at Rockefeller University (Moberg, 2012) . Hirsch focused on granulocytes, their recruitment, phagocytic activity, concomitant degranulation, and microbicidal activity by electron microscopy, imaging, and cell fractionation, influenced by the pioneering studies of Palade on exocrine secretion and of de Duve on lysosomes. Van Furth temporarily joined the laboratory: together, they organized a series of Leiden Conferences which documented progress in the field over several decades (Moberg, 2012) . Cohn and colleagues studied endocytic mechanisms in blood and tissue macrophages in culture: these included receptor-mediated pinocytosis and opsonic, antibody (Fc), and complement-receptor mediated phagocytosis. Mechanisms of ingestion, phagosome formation, acidification, and fusion with lysosomes and extensive plasma membrane recycling were investigated. A link of particle uptake to secretory responses was established. The group investigated infection by intracellular pathogens including Toxoplasma, Trypanosoma Cruzi, Legionella, M. Tuberculosis, M. Leprae, and later, HIV. These studies extended pioneering work at the Trudeau Institute by Mackaness and North on macrophage activation by BCG in vivo, followed by enhanced resistance to non-specific challenge with Listeria monocytogenes. Interferon gamma was subsequently shown by others to be the primary activation product of antigenstimulated CD4 Th1 lymphocytes and NK cells: IL-4 and 13 and Th2 cytokines induce a distinct alternative activation pathway. Several groups demonstrated that activated phagocytes used reactive oxygen and nitrogen metabolites to kill microbes. Cerami, Beutler, and others showed that secretory products of activated macrophages included TNF and other pro-inflammatory cytokines, as well as anti-inflammatory products such as IL-10, TGFb, and PGE2. In addition, phagocytosis by macrophages could stimulate release of chemokines, urokinase, and other neutral proteinases, able to act upon extracellular substrates, consistent with early speculations by Metchnikoff.
Picking up the theme of Metchnikoff's original interest, Cohn and Steinman (Steinman, 2012) , a later recruit and eventual co-director of the laboratory, investigated degradation of protein cargo after endocytosis by macrophages: they found this to be extensive, if not complete. Meanwhile, Unanue found that 15% of protein was not degraded and remained associated with a membrane fraction of macrophages, consistent with presentation of antigen-derived peptides to primed CD4 T lymphocytes. Subsequently, Steinman, Cohn, and colleagues identified the DC, a novel, macrophage-related cell type, as a potent antigen presenting cell (APC) able to activate naive T lymphocytes. This was associated with high expression of MHC antigen, shown by several groups to bind processed peptide for antigen presentation to T and B cell receptors. Immature DCs were efficient phagocytes, losing this activity upon maturation. A great deal has been learnt since about the mechanism of antigen uptake, processing, and presentation, including cross-presentation to CD8+ cytotoxic T lymphocytes.
The ability of phagocytes to distinguish foreign from self ligands in the absence of opsonins is an important aspect of microbial uptake. Janeway postulated the existence of so-called pattern recognition receptors (PRR) on the cell surface. Studies on microbial recognition pathways in Drosophila by Hoffmann and colleagues, the cloning of mammalian Toll-like receptors (TLR) by Medzhitov and Janeway, and studies on TNF signaling by Beutler, Akira, and others revealed the pathways of TLR sensing and receptor collaboration in cell activation and secretion. Phagocytic receptors form a specialized contact zone with target cell ligands, analogous to synapses, initiating engulfment (Gordon, 2016) . Selected TLR are present in intracellular phagocytic compartments. Within the cytosol of macrophages, there are other sensing systems that recognize nucleic acids, including foreign DNA and NODlike receptors for microbial components. Uptake of membrane-disrupting particles such as gout crystals, in combination with other stimuli, activate inflammasomes and Caspases, to generate IL-1 beta release.
A different aspect of phagocytic research which has flourished over recent decades relates to the recognition and clearance of naturally dying apoptotic/senescent cells, via scavenger and other non-opsonic receptors. These mediate uptake via phosphatidylserine and other ligands. Receptor deficiency for a complement protein, C1Q, can result in autoimmune disease such as lupus erythematosus. Henson and colleagues showed that apoptotic cell uptake is anti-inflammatory, appropriate for a physiologic process, unlike uptake of necrotic cells to initiate a pro-inflammatory response. Although Metchnikoff was not in a position to distinguish uptake of apoptotic from necrotic cells, he appreciated the importance of phagocytosis in clearance of damaged cells, in his own words ''One function of amoeboid mesoderm cells is to eat up those parts of the organism which have become useless'' (Tauber and Chernyak, 1991) . We now recognize that uptake of exogenous particles (heterophagy) is analogous to a more recently identified process termed autophagy, in which damaged organelles such as mitochondria can be sequestered by membranes for delivery to lysosomes and subsequent digestion. The light chain of myosin can contribute to this process, which plays a role in infection and inflammation. Uptake of particles can induce cell death, phagoptosis, highlighted by Guy Brown; conversely, macrophages can nibble parts from living cells without causing cell death, crinophagy, which is important in hormone processing.
Metchnikoff was aware that lymphohaemopoietic organs such as spleen and bone marrow contained populations of amoeboid phagocytic cells, as well as lung, liver, gut, skin, and kidney, without overt infection or inflammation and distinguished these macrophages from precursors in the blood (Gordon, 2016) . We now recognize that such ''resident'' tissue macrophages are an important part of the mononuclear phagocyte system, a term which replaced that of the reticulo-endothelial system (Van Furth, 1985) . Several studies have shown that many resident macrophage populations arise from yolk sac and fetal liver during organogenesis and then persist in adult life. The bone marrow can provide newly recruited monocytes from blood during inflammation and infection, giving rise to mixed populations of fetal and adult origin. These macrophages can form granulomas, organized structures of macrophages, fibroblasts, and other leukocytes, walling off foreign bodies, necrotic tuberculous tissue, or Schistosome eggs. Metchnikoff knew that Koch had noted that characteristic multinucleated, giant macrophages in tuberculosis contained mycobacteria. Metchnikoff would not have been surprised to learn from recent studies that such giant cells can acquire an enhanced phagocytic capacity compared with unfused cells (Gordon, 2016) . He also observed foamy, vacuolated macrophages in tuberculosis, associated with cheese-like extracellular material. Similar macrophages were found in arterial lesions of occlusive disease (atherosclerosis), later shown by Anitschkow to arise by lipid accumulation. Analysis of gene and protein expression by macrophages from different organs has revealed heterogeneity and specialization among microglia, the resident macrophages in the CNS, and macrophages in lung, gut, and liver. Microglia enter the brain during development and influence neurogenesis and synaptogenesis, sculpting non-functional synapses. We have almost no insight into the tissue microenvironmental factors which determine phenotypic adaptation. Finally, we should acknowledge that not all macrophages are phagocytic, e.g., marginal metallophils of spleen, nor that all phagocytic cells are myeloid leukocytes, viz., monocytes, macrophages, neutrophils, or DCs. Retinal pigment epithelial cells take up effete photoreceptors avidly, via a scavenger receptor, CD36, and Sertoli cells in the testis, which are not myeloid in origin, remove abnormal sperm. Epithelial cells can be induced to phagocytose apoptotic cells, and fibroblasts can also be regarded as occasional phagocytes.
Conclusion
To someone like myself who has been involved in macrophage research for 40 years, it has been remarkable how often Metchnikoff anticipated recent discoveries in the field. Of course, our hindsight might exaggerate his foresight, but in spite of obvious errors and omissions, he has proved to be a prescient guide for our time. I would like to draw attention to a few Metchnikoff-inspired speculations that deserve further investigation. I find it surprising that developmental biologists, with rare exceptions, remain relatively ignorant of his contributions regarding the role of phagocytosis in organogenesis and tissue remodelling. Macrophages appear in the embryo around midgestation, and it is well known that they participate as microglia in development of the brain, before and after birth. Combined with their presence at the placental maternal-fetal interface, their migratory capacity and ability to capture, transport, and replicate viruses makes it likely that they play a major role in the catastrophic impact of Zika virus on brain development. We still lack efficient and selective methods to deplete macrophages at specific stages of development. At the other end of life, we have little knowledge of their contribution, if any, to the aging process, other than as secondary participants. Can we benefit by selective enhancement of phagocytic clearance, for example, of amyloid deposits? Can we harness their homing and cytotoxic potential to seek out and destroy nascent and metastatic tumors, rather than providing trophic support, as seems to be the case? Can we exploit their immune adjuvant activities to improve vaccination strategies? Although Metchnikoff did not train in medicine, and often suffered unjust criticism on this account, he did try on many occasions to apply his insights to the amelioration of human suffering. An obvious example would be to define the nature and benefits of gastro-intestinal flora to prevent and treat inflammatory bowel disease. Finally, we need to reconstruct the genetic acquisition of phagocytosis as an essential part of the evolution of myeloid leukocytes, long before and concomitant with the phylogeny of histocompatibility genes and lymphocytes. The hypothesis of Lynn Margulis that mitochondria arose by the phagocytic capture of ancient bacteria is now widely accepted. There may be other examples during evolution in which the fundamental building blocks of phagocytosis became incorporated to perform novel functions in other cells, a memorial to the insights and tenacity of Metchnikoff's obsession with phagocytosis.
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